Evidence map›Paper›PMID 36357495›Full record

ArticleScientific reports2022

Logan D Stone, Adriana V F Massicano, Todd M Stevens, Jason M Warram, Anthony B Morlandt, Suzanne E Lapi, Hope M Amm

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Immuno-PET Imaging of EGFR withMolecular pharmaceutics · 2024
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Logan D StoneDepartment of Otolaryngology, University of Alabama at Birmingham, 1720 2nd Avenue South, VH G082, Birmingham, AL, 35294, USA.
Adriana V F MassicanoDepartment of Radiology, University of Alabama at Birmingham, 1824 6th Avenue South, WTI 310F, Birmingham, AL, 35294, USA.
Todd M StevensDepartment of Pathology, University of Alabama at Birmingham, 1802 6th Avenue South, NP 3548, Birmingham, AL, 35294, USA.
Jason M WarramDepartment of Otolaryngology, University of Alabama at Birmingham, 1720 2nd Avenue South, VH G082, Birmingham, AL, 35294, USA.
Anthony B MorlandtDepartment of Oral and Maxillofacial Surgery, Section of Oral Oncology, University of Alabama at Birmingham, 1919 7th Avenue South, Birmingham, AL, 35294, USA.
Suzanne E LapiDepartment of Radiology, University of Alabama at Birmingham, 1824 6th Avenue South, WTI 310F, Birmingham, AL, 35294, USA.ORCID 0000-0003-0090-0191
Hope M AmmDepartment of Oral and Maxillofacial Surgery, Section of Oral Oncology, University of Alabama at Birmingham, 1919 7th Avenue South, Birmingham, AL, 35294, USA. hopeamm@uab.edu.ORCID 0000-0003-2416-9575
University of Alabama at Birmingham · US

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
Hedgehog Pathway Activity and Targeting in KCOTR00DE023826 · NIDCR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI AMM, HOPE · 2017 to 2020
$813k
Non-Invasive Imaging of AmeloblastomasR21DE029603 · NIDCR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI AMM, HOPE · 2021 to 2022
$362k
Hedgehog Pathway Activity and Targeting in KCOTK99DE023826 · NIDCR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI AMM, HOPE · 2015 to 2016
$247k
NCI NIH HHS P30 CA013148NIDCR NIH HHS K99 DE023826NIDCR NIH HHS R00 DE023826NIDCR NIH HHS R21 DE029603
6 · The paper itself

Abstract

Accurate assessment of tumor margins with specific, non-invasive imaging would result in the preservation of healthy tissue and improve long-term local tumor control, thereby reducing the risk of recurrence. Overexpression of epidermal growth factor receptor (EGFR) has been used in other cancers as an imaging biomarker to identify cancerous tissue. We hypothesize that expression of EGFR in ameloblastomas may be used to specifically visualize tumors. The aims of this study are to measure the specificity of radiolabeled

Indexed as

AmeloblastomaAnimalsCell Line, TumorHumansMicePanitumumabPositron-Emission TomographyPositron Emission Tomography Computed TomographyTissue DistributionZirconiumPanitumumabZirconium

Identifiers

PMID36357495
PMCPMC9649768
OpenAlexW4309246550

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.